Sun Yat-sen University Cancer Center
Guangzhou,China
RecruitingCBP-1008-02
An Open-label，Multi-center, Phase Ia, Ib Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of a Weekly Regimen of CBP-1008 for Injection in Patients with Advanced Solid Tumors Positive for FOLR1 and/or TRPV6 Expression and Expansion in Selected Indications
Locations
Recruiting
The Fourth Hospital of Hebei Medical University
Shijiazhuang,China
No longer available